{"id":"W4406869302","doi":"10.1200/jco.2025.43.4_suppl.4","title":"Preliminary phase 1/1b dose expansion results of the bifunctional EGFR/TGFβ inhibitor ficerafusp alfa (BCA101) with pembrolizumab in patients with squamous cell carcinoma of the anal canal.","year":2025,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Colorectal and Anal Carcinomas","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Medicine; Pembrolizumab; Basal cell; Oncology; Internal medicine; Anal canal; Bifunctional; Cancer research; Cancer; Immunotherapy; Rectum","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001141967,0.0001894992,0.001091866,0.0002073814,0.00006776745,0.000004110598,0.0002840409,0.0002705216,0.00002967415],"category_scores_gemma":[0.001139705,0.0000858257,0.0004197385,0.0006230908,0.0004504684,0.00008083773,0.0001366471,0.001197889,5.218546e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002234033,"about_ca_system_score_gemma":0.003590915,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004272653,"about_ca_topic_score_gemma":0.001051896,"domain_scores_codex":[0.996092,0.0005127449,0.002136429,0.0002487668,0.000780093,0.0002299473],"domain_scores_gemma":[0.9953603,0.001352605,0.001947385,0.0003319877,0.0008390236,0.0001687401],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.2255359,0.01182205,0.7473853,0.0001508602,0.0001300856,0.0001822826,0.0002714727,0.0003213186,0.0003369518,0.00002545219,0.004256251,0.009582188],"study_design_scores_gemma":[0.06254384,0.04461968,0.8893304,0.0003257088,0.0004630322,0.00005907501,0.0002188158,0.000182917,0.0007967586,0.00002967159,0.001349351,0.00008072823],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9930205,0.0001798622,0.000005870965,0.00339693,0.0007183362,0.0004159932,0.00003059014,0.000002652376,0.002229225],"genre_scores_gemma":[0.9983848,0.00001001697,0.000109457,0.0006837962,0.0002762337,0.000004230239,0.000006466152,0.00001214572,0.0005128148],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.162992,"threshold_uncertainty_score":0.6370129,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02798824627886642,"score_gpt":0.3403073014110149,"score_spread":0.3123190551321485,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}